Related references
Note: Only part of the references are listed.Inhibition of microRNA-494-3p activates Wnt signaling and reduces proinflammatory macrophage polarization in atherosclerosis
Eva van Ingen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Macrophage Plasticity and Atherosclerosis Therapy
Ping Lin et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
The PCSK9 revolution: Current status, controversies, and future directions
Bruce A. Warden et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2020)
Macrophage polarization in atherosclerosis
Sai Yang et al.
CLINICA CHIMICA ACTA (2020)
Low-density lipoprotein receptor-related protein 6-mediated signaling pathways and associated cardiovascular diseases: diagnostic and therapeutic opportunities
Sheng Kang
HUMAN GENETICS (2020)
The role of Wnt signalling in development of coronary artery disease and its risk factors
Ya Liu et al.
OPEN BIOLOGY (2020)
Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
Dhruv Mahtta et al.
JAMA NETWORK OPEN (2020)
Extracellular vesicle signalling in atherosclerosis
E. Charla et al.
CELLULAR SIGNALLING (2020)
Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and update
Rasha Kaddoura et al.
JOURNAL OF DRUG ASSESSMENT (2020)
Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study
Moien A. B. Khan et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Comparative efficacy and safety of lipid-lowering agents in patients with hypercholesterolemia: A frequentist network meta-analysis
Zonglei Zhao et al.
MEDICINE (2019)
Therapeutic Targeting of LRP6 in Cardiovascular Diseases: Challenging But Not Wnt-Possible!
Pauline Labbe et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
Myocardial Infarction-From Atherosclerosis to Thrombosis Uncovering New Diagnostic and Therapeutic Approaches
Jathushan Palasubramaniam et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis
Laura Pasea et al.
BMC MEDICINE (2019)
Long-Term Efficacy and Safety of Evolocumab in Patients With Hypercholesterolemia
Michael J. Koren et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants
Henock G. Yebyo et al.
AMERICAN HEART JOURNAL (2019)
PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review
Yehuda Handelsman et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6
Felix Jansen et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2017)
Expression of miR-126 and its potential function in coronary artery disease.
Xiaoyan Wang et al.
AFRICAN HEALTH SCIENCES (2017)
The multifactorial nature of microRNAs in vascular remodelling
S. M. J. Welten et al.
CARDIOVASCULAR RESEARCH (2016)
Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Ira Tabas et al.
CIRCULATION RESEARCH (2016)
PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis
Anne Langsted et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
The Combined Hyperlipidemia Caused by Impaired Wnt-LRP6 Signaling Is Reversed by Wnt3a Rescue
Gwang-Woong Go et al.
CELL METABOLISM (2014)
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
Qiurong Ding et al.
CIRCULATION RESEARCH (2014)
Microvesicles as Cell-Cell Messengers in Cardiovascular Diseases
Xavier Loyer et al.
CIRCULATION RESEARCH (2014)
AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program-Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients
Nihar R. Desai et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Functional Analysis LRP6 Novel Mutations in Patients with Coronary Artery Disease
Yujun Xu et al.
PLOS ONE (2014)
MicroRNA Expression in Circulating Microvesicles Predicts Cardiovascular Events in Patients With Coronary Artery Disease
Felix Jansen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Rare Nonconservative LRP6 Mutations Are Associated with Metabolic Syndrome
Rajvir Singh et al.
HUMAN MUTATION (2013)
LRP5 and LRP6 in development and disease
Danese M. Joiner et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Distribution of macrophage polarization markers in human atherosclerosis
J. Lauran Stoger et al.
ATHEROSCLEROSIS (2012)
Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice
Friedrich Felix Hoyer et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
The Many Faces of Endothelial Microparticles
Francoise Dignat-George et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Wnt4/β-Catenin Signaling Induces VSMC Proliferation and Is Associated With Intimal Thickening
Aikaterini Tsaousi et al.
CIRCULATION RESEARCH (2011)
Association Between Serum Albumin and Mortality in Dialysis Patients Is Partly Explained by Inflammation, and Not by Malnutrition
Renee de Mutsert et al.
JOURNAL OF RENAL NUTRITION (2009)
LRP6 mutation in a family with early coronary disease and metabolic risk factors
Arya Mani et al.
SCIENCE (2007)
Share Paper
